Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.

Hess, U; Böhme, C; Rey, K; Senn, H J

Hess, U; Böhme, C; Rey, K; Senn, H J.

Affiliation

Hess U; Department C for Internal Medicine, Kantonsspital, St. Gallen, Switzerland.

Support Care Cancer ; 6(4): 402-9, 1998 Jul.

Article in En | MEDLINE | ID: mdl-9695210

Subject(s)

Amikacin/administration & dosage; Anti-Bacterial Agents/administration & dosage; Ceftazidime/administration & dosage; Enzyme Inhibitors/administration & dosage; Fever/drug therapy; Neoplasms/complications; Neutropenia/drug therapy; Penicillanic Acid/analogs & derivatives; Piperacillin/administration & dosage; Adolescent; Adult; Aged; Amikacin/adverse effects; Analysis of Variance; Ceftazidime/adverse effects; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors/adverse effects; Female; Fever/etiology; Humans; Male; Middle Aged; Neutropenia/etiology; Penicillanic Acid/administration & dosage; Penicillanic Acid/adverse effects; Piperacillin/adverse effects; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperacillin / Amikacin / Ceftazidime / Penicillanic Acid / Enzyme Inhibitors / Fever / Anti-Bacterial Agents / Neoplasms / Neutropenia Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 1998 Type: Article Affiliation country: Switzerland

Search on Google

XML

PubMed Links